BioSpace News Archive

Exelixis, Inc. (Nasdaq: EXEL) today announced that members of the company’s management team will participate in fireside chats at the following investor conferences in February.

AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab-ekko) has been approved in the US for self-administration in a pre-filled, single-use pen for patients aged 12 years and older with severe asthma.

Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”) announced today that it will be hosting a booth at the upcoming Medlab Middle East 2023 trade show held February 6-9 at the Dubai World Trade Centre.

Psycheceutical Bioscience, Inc. (OTCPK: BWVI) (“Psycheceutical” or the “Company”) is pleased to announce it has completed its pre-Investigational New Drug (“IND”) meeting with the U.S. Food and Drug Administration (FDA) and received positive feedback regarding the Company’s development plans for a novel NeuroDirect™ topical formulation of ketamine, intended for treating post-traumatic stress disorder (PTSD).

Menopause: The Journal of the North American Menopause Society today published “Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1),” detailing the results of the SWITCH-1 clinical trial aimed at identifying effective dosing for the investigational compound elinzanetant, a non-hormonal, selective neurokinin 1,3 receptor antagonist.

Varian, a Siemens Healthineers company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), as well as CE mark, for Halcyon® and Ethos™ radiotherapy systems featuring Varian’s HyperSight™ imaging solution.

Genesis Medical Plastics has developed production-scale calendering to convert medical grade and implantable PEEK into thin sheet and film.

Kymanox Corporation, a professional services company exclusively serving the life science industry, announced the acquisition of anteris medical GmbH and anteris helvetia AG.

Laxxon Medical, a pharma-technology company pioneering innovative 3D screen printed pharmaceutical solutions, announced today their participation in the BIO CEO & Investor Conference taking place at the New York Marriott Marquis on February 6-9, 2023.

Olympus announced it has been awarded a contract for its smoke evacuation products by Vizient Inc.